Supercharging the Launch of mRNA Products

Prepare for Dire Consequences

by Peter R. Breggin MD and Ginger Breggin

First published by AmericaOutLoud.com

She had a sparkling British accent and spoke crisply. Her responses to me were sprinkled with “brilliant” and “lovely.” She told me, “Now that first proof of concept” has been established, the next wave of mRNA products is coming down the pipeline with over $50 billion market share this year.

She is a representative of Hanson Wade, a company producing the 3rd Annual mRNA-Based Therapeutics Summit (“Supercharging the Next Wave of efficacious mRNA Therapeutics & Vaccines). Her job is “curating the audience for the upcoming 3rd mRNA-Based Therapeutics Summit this July.” She was calling me because I requested information about the summit and provided my contact details as requested.

She wanted to spend 15 minutes speaking with me about my interest in the conference and my role in mRNA development. I pleaded off the phone interview (my calendar is jammed today) and requested printed materials. Shortly after, I received a multi-paged PDF brochure3 for the conference, which is on the pricey side at $6100 for the Conference plus workshop day for Service and Solution Provider Pricing. Academic, Research Institutes, and Not for Profit pricing was set at $4346 for the same package.

Her follow-up email said, “From Moderna’s first In-Africa clinical trial of mRNA HIV vaccine to Merck’s use of messenger-RNA technology to fight cancer, the mRNA space is showing real promise in showing that it is being applied to other applications beyond COVID-19…I would be keen to discuss how your company is involved in the mRNA space and whether your work is focused on mRNA application to new disease areas and indications. What time works for you tomorrow for a quick 15-minute call?”

NIH Director Confirms Nanoparticle In-Human Tests

As an aside, I quickly looked up HIV mRNA vaccines and found “The Director’s Blog” for NIH reporting on the first-in-human tests. The acting Director of NIH, Lawrence A. Tabak, DDS, Ph.D., said:

“This nanoparticle, administered by injection, is designed to mimic a small, highly conserved segment of an HIV protein that allows the virus to bind and infect human cells. In the body, those nanoparticles launch an immune response and then quickly vanish. But because this important protein target for HIV vaccines is so tiny, its signal needed amplification for immune system detection.

“To boost the signal, the researchers started with a bacterial protein called lumazine synthase (LumSyn). It forms the scaffold, or structural support, of the self-assembling nanoparticle. Then, they added to the LumSyn scaffold 60 copies of the key HIV protein. This louder HIV signal is tailored to draw out and engage those very specific B cells with the potential to produce bnAbs. [emphasis added]

“As the first-in-human study showed, the nanoparticle vaccine was safe when administered twice to each participant eight weeks apart.”

Please note the section I have emphasized where the Director of NIH excitedly reports that the vaccine contains a bacterial protein that “forms a scaffold, or structural support, of the self-assembling nanoparticle.” WHAT??

Is this the same self-assembling kind of nanotechnology many have denied exists in vaccines? The kind of nanotechnology that Dr. Ana Maria Mihalcea, MD, Ph.D., has been researching and exposing along with dozens of other scientists and physicians around the world. Why yes, it is that kind of technology. Now admitted to exist by the Director of NIH, and also by the Office of the President of the United States in the newly released National Nanotechnology Initiative. So, mystery over. There is nanotechnology in the shots…that is what the mRNA platforms get loaded with!

Calling All Investigators

But back to my conversation with the curator of the upcoming mRNA summit. She had asked me if I could speak with her tomorrow. I don’t know if I have the time for that chat. But I need to share the 35-page brochure that I was sent so that some of our colleagues and investigative journalists can begin to help citizens understand the implications of the mRNA industry. The mRNA industry is here, whether we are prepared or not.

As the brochure says: “The mRNA revolution is here! Stretching beyond COVID-19 vaccines, the field has exploded with 800+ mRNA drugs currently in development and the acceleration of novel mRNA platforms into unchartered disease areas.” [emphasis added]

We called for the complete ban on mRNA products and platforms in January 2023.7 In December 2022; we identified the pre-COVID pandemic meeting that revealed that the hopeful mRNA vaccine industry wanted to “blow the system up” so that they could open the vaccine industry floodgates to mRNA-based products. Continuing Reading and Access Endnotes.

Find us at Twitter: @WeAreThePrey @GingerBreggin

Find us at our website: http://www.Breggin.com

Find us at http://www.AmericaOutLoud.com

Find us on Substack at: Peter and Ginger Breggin Exposing the Global Predators

First published on AmericaOutLoud.com.

Primary author Ginger Ross Breggin. She and her husband, Peter R. Breggin MD, are the authors of the bestselling new book “COVID-19 and the Global Predators: We are the Prey,” with introductions by top COVID-19 scientists and physicians, Peter A. McCullough MD, MPH; Elizabeth Lee Vliet MD; and Vladimir “Zev” Zelenko MD. Over 120,000 sold.

E-Pub & Kindle & Nook book sale of COVID-19 and the Global Predators: $2.99

Amazon.com, Barnes and Nobles, and bookstores online.

Special Paperback Discount in the US at WeAreThePrey.com

The audiobook of COVID-19 and the Global Predators: We are the Prey, by Peter and Ginger Breggin is available at Amazon.com.

Get your copy today from Amazon.com

OVER 120,000 COPIES SOLD

COVID-19 and the Global Predators: We are the Prey, authored by Peter R. Breggin MD and Ginger Ross Breggin, now in bookstores everywhere. Bulk quantities of books available at special discount–contact us at bregginbooks@hotmail.com.

#1 Bestseller on Amazon*

COVID-19 and the Global Predators: We Are the Prey by the Breggins

*in Health Care Delivery